Clinical Trials

Certolizumab in psoriasis

Certolizumab pegol improved health-related quality of life in patients with psoriasis: Data from a phase II study

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here